Diffusion Pharmaceuticals (NASDAQ:DFFN) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 1.3 % DFFN stock opened at $4.20 on Friday. The stock has a market capitalization of $8.56 million, a P/E ratio […]